ARTICLE | Company News
TTH, Biogenesys MS deal
December 5, 2001 8:00 AM UTC
Transition Therapeutics (CDNX:TTH) acquired IP from Biogenesys to methyldonor technology to treat multiple sclerosis (MS) and other diseases. TTH said the IP relates to its combination interferon prod...